Peripheral neuropathy in patients with HIV infection: Consider dual pathology

Sexually Transmitted Infections

Volumn 78, Issue 6, 2002, Pages 462-463

  Miller, R F ^a   Bunting, S ^a   Sadiq, S T ^b   Manji, H ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Camden Primary Care Trust   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; RITONAVIR; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MUSCLE BIOPSY; NERVE BIOPSY; NEUROPHYSIOLOGY; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; CHARCOT-MARIE-TOOTH DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; STAVUDINE;

EID: 0036916578     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.78.6.462     Document Type: Article

References (8)

1. Manji H. Neuropathy in HIV infection. Curr Opin Neurol 2000;13:589-92.
2. Gherardi RK, Chretein F, Delfau-Laurue M-H, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome. An HIV neuropathy, not a lymphoma. Neurology 1998;50:1041-4.
3. Bennett CL, Chance PF. Molecular pathogenesis of hereditary motor, sensory and autonomic neuropathies. Curr Opin Neurol 2001;14:621-7.
4. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-51.
5. Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol 1998;23:461-5.
6. Moulangier A, Authier F-J, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997;41:438-45.
7. Moyle GJ, Sadler M. Peripheral neuropathy with nucleoside antiretrovirals-risk factors, incidence and management. Drug Safety 1998;19:481-94.
8. Moore RD, Wong WE, Keruly JC, et al. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 2000;14:273-6.